Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants
Status:
Completed
Trial end date:
2021-06-26
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of vonoprazan (20 mg) and
lansoprazole (30 mg) following single (Day 1) and multiple doses (Day 7).